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Introduction. The aim of this study was to estimate the significance of TSH, thyroid peroxidase antibody (TPOAb), and mild
(subclinical) hypothyroidism in women fromTheDanish General Suburban Population Study (GESUS) on the number of children
born, the number of pregnancies, and the number of spontaneous abortions.Methods. Retrospective cross sectional study of 11254
women participating in GESUS. Data included biochemical measurements and a self-administrated questionnaire. Results. 6.7%
had mild (subclinical) hypothyroidism and 9.4% prevalent hypothyroidism. In women with mild hypothyroidism TPOAb was
significantly elevated and age at first child was older compared to controls. TSH and TPOAb were negatively linearly associated
with the number of children born and the number of pregnancies in the full cohort in age-adjusted andmultiadjusted models. TSH
or TPOAb was not associated with spontaneous abortions. Mild (subclinical) hypothyroidism was associated with a risk of not
having children and a risk of not getting pregnant in age-adjusted and multiadjusted models. Prevalent hypothyroidism was not
associated with the number of children born, the number of pregnancies, or spontaneous abortions. Conclusion. Impaired fertility
is associated with TSH, TPOAb, and mild (subclinical) hypothyroidism in a Danish population of women.
1. Introduction
Through the last twenty years, the knowledge on thyroid
disease during pregnancy has rapidly expanded. It is well
documented that women with overt hypothyroidism during
pregnancy have an increased risk of pregnancy loss and
adverse pregnancy outcome [1–3], but the consequences of
subclinical hypothyroidism and the significance of concomi-
tant thyroid peroxidase antibodies (TPOAb) are debated [4–
6]. Subclinical hypothyroidism is a condition in which a
slightly raised thyroid stimulating hormone (TSH) signal is
representing an early, mild thyroid failure [7].
The persistency of mild (subclinical) hypothyroidism
may differ according to ethnicity and age; however, TSH
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increase with age [8] as well as the prevalence of TPOAb
positivity is increasing with age [9]. Further the presence of
TPOAbdoes seem important, as resolution to euthyroidism is
reported much higher in TPOAb negative subjects compared
to TPOAb positive [10]. Women with asymptomatic autoim-
mune thyroid disorders, who are euthyroid in early preg-
nancy, carry a significant risk of developing hypothyroidism
progressively during gestation [11].
The aim of this study was to estimate the significance
of TSH, thyroid peroxidase antibody (TPOAb), and mild
(subclinical) hypothyroidism in women from The Danish
General Suburban Population Study (GESUS) on the number
of children born, the number of pregnancies, and the number
of spontaneous abortions.
2. Material and Methods
2.1. Study Population. TheDanishGeneral Suburban Popula-
tion Study (GESUS)was initiated in January 2010 andfinished
in October 2013. GESUS is a cross sectional study of the adult
Danish suburban general population in NaestvedMunicipal-
ity (70 km south of Copenhagen) selected on the basis of
the Danish Central Population Register Code. All individuals
older than 30 years were invited. Due to financial reasons
the GESUS study was designed to invite only 25% of younger
women of 20–29 years age influencing the distribution of age
[12].
The health examination included a comprehensive phys-
ical examination (body mass index (BMI)), biochemical tests
and a self-administrated questionnaire (prevalent disease
(diabetes mellitus, hypothyroidism, and hyperthyroidism),
antihypertensive and cholesterol lowering medication, thy-
roid and antithyroid medication, contraception, smoking,
income, education, employment, the number of pregnancies,
the number of children born, age of first child, and the
number of spontaneous abortions).Thequestionnaire did not
include questions about induced abortion.
The GESUS study questionnaire can be viewed at
http://www.p3gobservatory.org/catalogue.htm;jsessionid=
ACE6E593F10B80573D64E965FA2DB3D8?measureId=38.
GESUS had an overall participation rate of women of 45%
(𝑁 = 11565). In this study we included participants of
European origin (99% Danish) (𝑁 = 11387) and excluded
participants with missing values of TSH, fT
4
, and tT
3
(𝑁 = 50) and missing values of the number of pregnancies,
the number of children born, and the number of spontaneous
abortions (𝑁 = 31). Thus, we ended up with a total of 11254
women. Prevalent hypothyroidism was defined as history of
hypothyroidism or intake of T
4
/T
3
medication, and prevalent
hyperthyroidism was defined as history of hyperthyroidism
or intake of antithyroid medication.
2.2. Biochemical Variables. Thyroid hormones within the
reference interval were defined as fT
4
= 10.0–24.0 pmol/L,
tT
3
= 1.20–2.90 nmol/L, and TSH = 0.4–3.7mU/L. Mild
(subclinical) hypothyroidismwas defined as TSH > 3.7mU/L
and fT
4
and tT
3
within the reference interval, no history
of thyroid disease, and no intake of T
4
/T
3
or antithyroid
medication. Controls were defined as having 0.4 < TSH ≤
3.7mU/L and fT
4
and tT
3
within the reference interval,
no history of thyroid disease, and no intake of T
4
/T
3
or
antithyroid medication [13, 14].
Thyroid peroxidase antibody (TPOAb) positivity was
defined by the cut-off value of TPOAb > 60U/mL. All
biochemical tests were performed at the same laboratory at
Naestved Hospital.
Measurements of TSH and of thyroid hormones-free
thyroxin (fT
4
) and total triiodothyronine (tT
3
) were per-
formed using an electrochemiluminescent immunoassay
(Roche Cobas 6000, Basel, Switzerland). Reference ranges for
TSH are 0.40–3.70mU/L (CV < 7%), fT
4
reference range
10.0–24.0 pmol/L (CV < 5%), and tT
3
reference range 1.20–
2.90 nmol/L (CV< 4%). TPOAbwasmeasured byKRYPTOR
antiTPOn (BRAHMS,Henigsdorf, Germany), with detection
limit of 10 kU/L.
2.3. Statistics. All statistical analyses were performed using
Stata version 13.0 for Windows (StataCorp, College Station,
TX, USA). A value of 𝑃 < 0.05 was considered statistically
significant.
Continuous variables were compared between groups
using Mann-Whitney-𝑈 test. Normal distribution was
assessed visually using histograms and the Stata code “glad-
der” for the best transformation of nonnormally distributed
variables. TSH and TPOAb were not normally distributed
and therefore log-transformed (logTSH and logTPOAb).
Categorical variables were compared using a Pearson 𝜒2 test.
We performed the following statistical models:
(1) for the full cohort of women:
(a) linear regression analyses of TSH and TPOAb of
children born and the number of pregnancies,
(b) logistic regression for spontaneous abortion;
(2) for women with prevalent hypothyroidism versus
controls:
(a) logistic regression analyses for ≥1 children born,
≥1 pregnancies, and spontaneous abortion;
(3) for women with subclinical hypothyroidism versus
controls:
(a) logistic regression analyses for ≥1 children born,
≥1 pregnancies, and spontaneous abortion.
Models designed were either age-adjusted or multifactorially
adjusted using age, BMI, diabetes, contraception, education,
income, employment, smoking, antihypertensive medica-
tion, cholesterol lowering medication, and menopause as
listed in Table 1. TPOAb was not a significant confounder in
the models. There was no statistical interaction with age or
menopause.
2.4. Ethical Considerations. The study was approved by the
Regional Ethics Committee of Zealand, Denmark (Reg.
number RVK SJ-177, SJ-113, and SJ-114), registered with
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Table 1: Characteristics of women inThe Danish General Suburban Population Study (GESUS).
All Mild (subclinical) hypothyroidism
No yes 𝑃-value
𝑁 (%) 11254 (100) 8770 758
Age 56.3 (45.5–66.2) 55.4 (44.8–65.6) 55.6 (44.9–65.9) 0.43
Menopause, yes (%) 7129 (63.4) 5405 (61.6) 463 (61.1) 0.77
TSH, mU/L 1.8 (1.2–2.6) 1.7 (1.2–2.3) 4.6 (4.1–5.5) <0.001
Total T3, nmol/L 1.6 (1.5–1.9) 1.7 (1.5–1.9) 1.6 (1.5–1.8) 0.38
Free T4, pmol/L 15 (14–17) 15 (14–17) 14 (13–15) <0.001
TPOAb, U/mL 13 (20–32) 19 (12–27) 28 (15–699) <0.001
Body mass index (BMI), kg/m2 25.3 (22.6–28.8) 25.2 (22.5–28.7) 25.5 (22.8–29.2) 0.06
Smoker, yes (%) 1899 (16.9) 1527 (17.5) 66 (8.7) <0.001
Prevalent hypothyroidism, yes (%) 922 (9.4) NA NA
Prevalent hyperthyroidism, yes (%) 391 (4.2) NA NA
Diabetes mellitus, yes (%) 576 (5.1) 392 (4.5) 40 (5.3) 0.31
Antihypertensive medication, yes (%) 2457 (21.8) 1816 (20.7) 140 (18.5) 0.14
Cholesterol lowering medication, yes (%) 1510 (8.5) 1096 (12.5) 91 (12.0) 0.69
Contraception, yes (%) 953 (8.5) 772 (8.8) 66 (8.7) 0.93
Income below EUR 60,000 C 4744 (43.7) 3588 (42.4) 292 (40.1) 0.25
Unemployment, yes (%) 6284 (55.8) 3690 (42.1) 318 (42.0) 0.95
Education, no (%) 1713 (15.2) 1291 (14.7) 95 (12.5) 0.57
Age at 1st child born 25 (22–28) 25 (22–28) 25 (22–29) 0.02
No children born,𝑁 (%) 1171 (10.5) 897 (10.3) 98 (13.0) 0.02
No pregnancies,𝑁 (%) 952 (8.5) 733 (8.4) 77 (10.2) 0.09
Spontaneous abortion, yes (%) 2261 (21) 1747 (20.8) 149 (20.6) 0.87
For continuous variables: median (interquartile range).
For SCH, 𝑃 value: Chi-square for categorical comparisons and ranksum or Kruskal-Wallis test for continuous comparisons.
ClinicalTrial.gov (NCT01335802), and reported to theDanish
Data Protection Agency.
The study conformed to the principles of the Declaration
of Helsinki. Written consent was obtained from all partici-
pants prior to participation in the GESUS study.
3. Results
Table 1 shows characteristics of women. In total, 758
(6.7%) had mild (subclinical) hypothyroidism, 9.4% preva-
lent hypothyroidism, and 4.2% prevalent hyperthyroidism. In
women with mild hypothyroidism TPOAb was significantly
elevated and age at first child was older compared to controls.
LogTSH and logTPOAb were negatively linearly associated
with the number of children born and number of pregnancies
in the full cohort in age-adjusted and multiadjusted models
(Table 2). logTSH or logTPOAb was not associated with
spontaneous abortions.
Mild (subclinical) hypothyroidism was associated with a
risk of not having children and a risk of not getting pregnant
in age-adjusted and multiadjusted models. Prevalent hypo-
thyroidism was not associated with the number of children
born, the number of pregnancies, or spontaneous abortions
(Table 3).
4. Discussion
In the present study, we showed that with higher TSH levels
the less number of children born and the less number of
pregnancies. Furthermore, with higher TPOAb levels the
less number of children born. Coefficients for logTSH were
higher than for logTPOAb; thus, the effect of TSH seems
higher than for TPOAb. Mild hypothyroidism was also
associated with a higher age of first child born and risk of
not having children and not getting pregnant. TPOAb was
not a significant confounder in the models, and there was no
interaction with age.
This analysis is cross sectional and in a way retrospective
for those women who are now menopausal. Also, for women
who are premenopausal we may not have the life-time full
number of children born, the number of pregnancies, and the
number of spontaneous abortions.
The prevalence of TSH elevations increases with age [9]
while the fertility declines. We only have age of the mother
at the birth of her 1st child. We cannot adjust for age of the
mother at the birth of her 1st child as this only applies for
those who have had children; thus, those with no children
have missing values in that category. We have included the
information in Table 1, and it appears that there is a significant
difference between those with mild hypothyroidism and
4 Journal of Pregnancy
Table 2: Association between TSH (mU/L) and TPOAb (U/mL) levels and the number of children born, the number of pregnancies, and
spontaneous abortion.
Age-adjusted Multiadjusted∗
Coefficient (95% CI) 𝑃 value Coefficient (95% CI) 𝑃 value
Number of children born
log TSH −0.046 (−0.068–(−0.023)) <0.001 −0.050 (−0.072–(−0.0272)) <0.001
log TPOAb −0.020 (−0.037–(−0.003)) 0.02 −0.021 (−0.038–(−0.004)) 0.02
Number of pregnancies
log TSH −0.081 (−0.132–(−0.030)) 0.002 −0.085 (−0.136–(−0.033)) 0.001
log TPOAb −0.019 (−0.055–0.017) 0.31 −0.021 (−0.058–0.016) 0.27
Spontaneous abortion (yes versus no)
log TSH 0.96 (0.91–1.01) 0.12 0.95 (0.89–1.01) 0.08
log TPOAb 1.00 (0.95–1.04) 0.86 1.00 (0.96–1.04) 0.94
∗Multiadjusted model: age, menopause, BMI, smoking, diabetes, antihypertensive medication, cholesterol lowering medication, contraception, income,
unemployment, and education.
Correlation between TSH and TPOAb and number of children born and number of pregnancies are measured was by linear regression.
Association between TSH and TPOAb and spontaneous abortion (yes vs. no) was by logistic regression.
Table 3: Table of odds ratios for ≥1 children born, ≥1 pregnancy, and spontaneous abortion in patients with prevalent hypothyroidism versus
controls and in patients with mild (subclinical) hypothyroidism versus controls.
Prevalent hypothyroidism Mild (subclinical) hypothyroidism
Odds ratio
(95% CI) 𝑃 value
Odds ratio
(95% CI) 𝑃-value
Odds ratio
(95% CI) 𝑃-value
Odds ratio
(95% CI) 𝑃-value
Age-adjusted Multiadjusted∗ Age-adjusted Multiadjusted∗
≥1 children born versus none 0.84(0.67–1.06) 0.14
0.87
(0.69–1.10) 0.25
0.75
(0.60–0.94) 0.01
0.71
(0.56–0.90) 0.004
≥1 pregnancy versus none 0.83(0.65–1.07) 0.15
0.85
(0.66–1.1) 0.22
0.79
(0.61–1.01) 0.06
0.75
(0.58–0.97) 0.03
Spontaneous abortion (yes versus
no)
1.05
(0.88–1.24) 0.6
1.02
(0.89–1.22) 0.78
0.99
(0.82–1.19) 0.87
0.96
(0.79–1.17) 0.69
∗Multiadjusted model: age, menopause, BMI, smoking, diabetes, antihypertensive medication, cholesterol lowering medication, contraception, income,
unemployment, and education.
controls. Furthermore, were we not able to perform analyses
of pregnancy and child birth history restricted to only within
few years of the TSH examination.
We were not able to detect an effect on spontaneous
abortion. This may be caused by the fact that, during fertile
life, early miscarriage may have gone unnoticed or been
“forgotten.” Liu et al. had recently reported that women
with a combination of subclinical hypothyroidism and thy-
roid autoimmunity were found to have the highest risk
of miscarriage before 20 weeks of gestation compared to
only TPOAb positivity or subclinical hypothyroidism [15].
In contrast, previous prospective studies have confirmed an
association between mild hypothyroidism during pregnancy
and pregnancy loss [16]. Allan et al. showed that stillbirth
was significantlymore frequent inwomen having TSHhigher
than 6.0mU/L but they did not distinguish between overt
and mild hypothyroidism [1]. Benhadi et al. reported that
the risk of child loss was increased with higher levels of
maternal TSH, whereas concentrations of maternal fT
4
and
child loss were not associated [17]. Abalovich et al. observed
that the evolution of pregnancy did not depend on whether
the hypothyroidism was overt or mild but depended on
adequate treatment during pregnancy. If the treatment was
optimized, the risk of complications was minimized [18].
These findings correspond to our results, since the odds
ratios for ≥1 pregnancy and child birth versus none were
not significant comparing prevalent hypothyroidism versus
controls reflecting a well-treated condition. Furthermore that
mild hypothyroidism is representing nonadequate treatment
and mild thyroid failure was associated with a risk of not
having children and a risk of not getting pregnant.
Accordingly, in our study we observed that elevated TSH
above the upper reference limit in mild hypothyroidism
correlated with the number of pregnancies and child births.
Several studies have reported a possible association between
thyroid dysfunction during pregnancy and specific adverse
pregnancy outcome like preeclampsia [19, 20], placental
abruption, or preterm delivery [21, 22].
It has been suggested that higher TSH and TPOAb posi-
tivity were independently associated with lower likelihood of
reversion to euthyroidism [10]. In a 20-year follow-up study,
an increased serum TSH level was predictive of progression
to overt hypothyroidism, and the annual rate of progression
to overt hypothyroidism was more than 4% in women with
both raised serum TSH and antithyroid antibodies [23].
Glinoer et al. showed a trend towards slightly higher serum
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TSH levels in women with thyroid autoimmunity in the
first trimester of pregnancy compared to women without
thyroid autoimmunity and that women with asymptomatic
autoimmune thyroid disease who were euthyroid in early
pregnancy carried a significant risk of developing hypothy-
roidism progressively during gestation, despite a marked
reduction in antibody titers [11].
This retrospective cross sectional study showed that
among women without any history of thyroid disease or anti-
hyperthyroid/antihypothyroid medication 6.7% had mild
(subclinical) hypothyroidism. The prevalence of mild hypo-
thyroidism was comparable to previous studies [24] like
the Colorado study in which 8.5% had subclinical hypothy-
roidism increasing with age [25] explained by the chosen
value of TSH cut-off defining mild hypothyroidism.
The presence of mild hypothyroidism influenced the level
of fT
4
within the reference range as fT
4
was decreased in
women with mild hypothyroidism. This could be explained
by an increased intracellular deiodination of T
4
to T
3
in
women with mild hypothyroidism to avoid decreased levels
of active intracellular thyroid hormone concentrations. A
major problem is to determine separate effects of TPOAb
positivity and mild hypothyroidism. We are not able to
determine the status during pregnancy as the present study
is retrospective, but it seems unlikely that TPOAb would
have an effect directly on metabolism and peripheral thyroid
hormone regulated cellular function. However, we cannot
exclude the possibility that the women presenting with mild
hypothyroidism have had a previous normalized TSH level.
This population studywas performed inNaestvedMunic-
ipality eastern Denmark representing a mild iodine defi-
ciency [26]. In Denmark, the iodine intake was stable at a
low level for many years and in 2000, the mandatory iodine
fortification of bread salt and household salt began. Follow-
up studies reported an increase in prevalence of hypothyroid-
ism [27] and TPOAb positivity especially among younger
women [28].
The present study is limited by the fact that all clinical
observations are self-reported questionnaire data. Further-
more, we did not have any information about the numbers
of induced abortions which could influence the data of
child births although it is rarely recommended to induce an
abortion only due to high levels of TSH during first trimester
of pregnancy.
In addition, individuals were classified based on a single
blood test; thus, we cannot distinguish between transient and
permanent TSH elevation; however, Somwaru et al. showed
that subclinical hypothyroidism was persistent in 56% after
4-year follow-up [10]. Finally, due to financial reasons the
GESUS study was designed to invite only 25% of younger
women aged 20–30 years old influencing the distribution of
age.
The strength of our study was the high number of
participants with blood samples of TSH, fT
4
, tT
3
, andTPOAb
in 11254 women. Furthermore, for the analyses of mild
(subclinical) hypothyroidism we excluded women with any
self-reported thyroid disease or use of T
4
/T
3
or antithyroid
medication and only compared euthyroid and mild hypothy-
roid women.
5. Conclusion
Taken together, we observed that with higher TSH levels
the less number of children born and the less number of
pregnancies. Furthermore, with higher TPOAb levels the less
number of children born. Mild hypothyroidism was also
associated with a higher age of first child born and risk of
not having children and not getting pregnant. In conclusion,
we observed that impaired fertility is associated with TSH,
TPOAb, and mild (subclinical) hypothyroidism in a Danish
population of women.
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